Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy (Q34187436)

31 July 2017

1 reference

title

Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy (English)

1 reference

31 July 2017

1 reference

1 reference

X D Yang

1

1 reference

31 July 2017

X C Jia

2

1 reference

31 July 2017

J R Corvalan

3

1 reference

31 July 2017

P Wang

4

1 reference

31 July 2017

C G Davis

5

1 reference

31 July 2017

1 April 2001

1 reference

Critical Reviews in Oncology Hematology

31 July 2017

1 reference

31 July 2017

38

1 reference

31 July 2017

17-23

1 reference

31 July 2017

1

1 reference

Continuous cultures of fused cells secreting antibody of predefined specificity

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7

7 January 2021

Reshaping human antibodies for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7

7 January 2021

Analysis of homozygous mutant chimeric mice: deletion of the immunoglobulin heavy-chain joining region blocks B-cell development and antibody production

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7

7 January 2021

Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7

7 January 2021

Germ-line transmission and expression of a human-derived yeast artificial chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7

7 January 2021

Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7

7 January 2021

Regulation of B cell development by variable gene complexity in mice reconstituted with human immunoglobulin yeast artificial chromosomes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7

7 January 2021

Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7

7 January 2021

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7

7 January 2021

Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7

7 January 2021

Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7

7 January 2021

Receptor blockade with monoclonal antibodies as anti-cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7

7 January 2021

Therapeutic application of anti-growth factor receptor antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7

7 January 2021

The human EGF receptor as a target for cancer therapy: six new rat mAbs against the receptor on the breast carcinoma MDA-MB 468.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7

7 January 2021

Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7

7 January 2021

10.1016/S1040-8428(00)00134-7

Identifiers

DOI

1 reference

31 July 2017

1 reference